Trials / Unknown
UnknownNCT05173090
Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery | Visual analog scale 15 min after arrival in the recovery room, then H+4, H+6, H+12, H+24 and one week after the operation |
Timeline
- Start date
- 2022-01-15
- Primary completion
- 2022-06-30
- Completion
- 2022-07-30
- First posted
- 2021-12-29
- Last updated
- 2021-12-29
Source: ClinicalTrials.gov record NCT05173090. Inclusion in this directory is not an endorsement.